280 related articles for article (PubMed ID: 31653485)
1. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?
Bigeh A; Sanchez A; Maestas C; Gulati M
Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485
[TBL] [Abstract][Full Text] [Related]
2. Controlling leukocyte trafficking in IBD.
Veny M; Fernández-Clotet A; Panés J
Pharmacol Res; 2020 Sep; 159():105050. PubMed ID: 32598943
[TBL] [Abstract][Full Text] [Related]
3. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
[TBL] [Abstract][Full Text] [Related]
4. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
Kristensen SL; Lindhardsen J; Ahlehoff O; Erichsen R; Lamberts M; Khalid U; Torp-Pedersen C; Nielsen OH; Gislason GH; Hansen PR
Europace; 2014 Apr; 16(4):477-84. PubMed ID: 24108228
[TBL] [Abstract][Full Text] [Related]
6. Advances in understanding the role of cytokines in inflammatory bowel disease.
Bevivino G; Monteleone G
Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):907-915. PubMed ID: 30024302
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
Liu Y; Wang X; Hu CA
Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.
Thiebault H; Boyard-Lasselin P; Guignant C; Guillaume N; Wacrenier A; Sabbagh C; Rebibo L; Brazier F; Meynier J; Nguyen-Khac E; Dupas JL; Goëb V; Fumery M
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):876-81. PubMed ID: 27101404
[TBL] [Abstract][Full Text] [Related]
9. The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
Rogler G; Zeitz J; Biedermann L
Dig Dis; 2016; 34 Suppl 1():48-55. PubMed ID: 27548430
[TBL] [Abstract][Full Text] [Related]
10. Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
Godat S; Fournier N; Safroneeva E; Juillerat P; Nydegger A; Straumann A; Vavricka S; Biedermann L; Greuter T; Fraga M; Abdelrahman K; Hahnloser D; Sauter B; Rogler G; Michetti P; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):612-620. PubMed ID: 29384798
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.
Sinh P; Cross RK
Gastroenterol Hepatol (N Y); 2024 Apr; 20(4):204-215. PubMed ID: 38682122
[TBL] [Abstract][Full Text] [Related]
12. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.
Billmeier U; Dieterich W; Neurath MF; Atreya R
World J Gastroenterol; 2016 Nov; 22(42):9300-9313. PubMed ID: 27895418
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease: an increased risk factor for neurologic complications.
Morís G
World J Gastroenterol; 2014 Feb; 20(5):1228-37. PubMed ID: 24574797
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Bowel Disease and Cardiovascular Diseases.
Chen B; Collen LV; Mowat C; Isaacs KL; Singh S; Kane SV; Farraye FA; Snapper S; Jneid H; Lavie CJ; Krittanawong C
Am J Med; 2022 Dec; 135(12):1453-1460. PubMed ID: 36058305
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology and the pathogenesis of inflammatory bowel disease.
Karlinger K; Györke T; Makö E; Mester A; Tarján Z
Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation.
Weissman S; Sinh P; Mehta TI; Thaker RK; Derman A; Heiberger C; Qureshi N; Amrutiya V; Atoot A; Dave M; Tabibian JH
World J Gastrointest Pathophysiol; 2020 Aug; 11(5):104-113. PubMed ID: 32832194
[TBL] [Abstract][Full Text] [Related]
18. [Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)].
Jantchou P; Monnet E; Carbonnel F
Gastroenterol Clin Biol; 2006; 30(6-7):859-67. PubMed ID: 16885870
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
Cappello M; Licata A; Calvaruso V; Bravatà I; Aiello A; Torres D; Della Corte V; Tuttolomondo A; Perticone M; Licata G; Craxì A; Cammà C
Eur J Intern Med; 2017 Jan; 37():83-89. PubMed ID: 27773555
[TBL] [Abstract][Full Text] [Related]
20. Arterial structure and function in inflammatory bowel disease.
Zanoli L; Rastelli S; Inserra G; Castellino P
World J Gastroenterol; 2015 Oct; 21(40):11304-11. PubMed ID: 26523102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]